Articles from Life Spine

Life Spine, a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spinal disorders, announced today its ProLift® expandable interbody portfolio has been evaluated and confirmed as MR Conditional in accordance with ASTM standards.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the ARx SAI (Sacral Alar Iliac) Spinal Fixation System.

On December 21, 2023, Life Spine settled its litigation against Aegis Spine, Inc, whereby the parties have agreed to an order issued by the United States District Court, Northern District of Illinois, permanently prohibiting the marketing or sale of the AccelFix-XT line of medical devices in the United States. The order prevents Aegis Spine and any business entities and/or persons controlled directly or indirectly by Aegis Spine, and any business entities and/or persons in active concert or participation with Aegis Spine from, among other things, “Developing, manufacturing, marketing, promoting, advertising, distributing, transferring, assigning, sharing, disclosing, selling, offering for sale, seeking hospital registration of, or submitting a response to a request for proposal for any items in the AccelFix-XT line of medical devices.” In addition, L&K Biomed and L&K Spine have committed to never sell or directly or indirectly cause to be sold the AccelFix-XT line of medical devices within the United States.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has published a new retrospective study examining the effect of expandable versus static interbody implants via the Journal of Spine Surgery (JSS).

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of ARx Spinal Fixation System.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the TruLift Lateral Expandable Spacer System and Lateral Plate System.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of ProLift Micro Endoscopic Expandable Spacer System.

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the GHOST 3D-Printed Titanium Spacer Systems.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company has sold over 41,000 Micro Invasive Expandable Implants.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that is has received clearance from the U.S. Food & Drug Administration (FDA) to market SImpact SI Joint Fixation System for Posterior-Oblique approaches.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the first surgical cases of DYNA-LINK Titanium with Barb Fixation.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company will present at the 40th Annual J.P. Morgan Healthcare Conference.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the ProLift micro Expandable Spacer System.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it would be showcasing its complete line up of Micro Invasive procedural solutions, which includes 13 Expandable Interbody devices making it one of the largest and most innovative portfolios within the spine fusion market, at the 36th annual meeting of the North American Spine Society (NASS) in Boston from September 29 through October 1, 2021.

Life Spine won a ruling in the Seventh Circuit Court of Appeals affirming the District Court’s preliminary injunction, which prohibits Aegis Spine, Inc. and its business partners from marketing, selling, or distributing devices in the AccelFix-XT product line.

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the continued adoption and success of the PROLIFT Wedge Expandable Spacer System.

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the completion of the first surgeries with the TRULIFT Expandable Spacer System.

Life Spine won a second ruling barring Aegis Spine, Inc. from marketing, selling, or distributing devices in its AccelFix-XT product line.

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PROLIFT Lateral HELO Fixation System.

Life Spine, a leading medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spinal disorders, announced today a 23% revenue growth in their Micro Invasive Expandable Lateral Spacer Systems from Q1 2021 over Q4 2020.